Table 3.

 Association between use of statin and mortality

Outcome	No of patients	No (%) deaths	Age and sex adjusted effect estimate: hazard ratio (99% CI)	Fully adjusted effect estimate: hazard ratio (99% CI)
Mortality on day of pneumonia diagnosis
Did not use statin	3 615	686 (19)
Used statin	942	95 (10)
Mortality within 6 months of pneumonia, excluding deaths on day of pneumonia*
Did not use statin	2 927	578 (20)	–	–
Used statin	847	109 (13)	0.62 (0.47 to 0.81)	0.67 (0.49 to 0.91)
All mortality after index date (regardless of pneumonia status)*
Did not use statin	308 730	32 445 (11)	–	–
Used statin	51 397	4 718 (9)	0.95 (0.91 to 0.99)	0.82 (0.79 to 0.86)

*Analysis restricted to patients with comparable propensity scores.